Hints and tips:
Related Special Reports
...About 40 per cent of the votes cast at the group’s annual meeting in 2021 were against the remuneration plan, which is set every three years....
...Under the approved plans, Soriot could earn a maximum of £18.7mn....
...Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid DKr68mn (£7.8mn) last year....
...But Hardy, who worked on a similar plan with Anderson at Genentech, insisted “it really does work”. Profit per employee shot up almost 70 per cent within five years, Hardy said....
...Health commissioner Stella Kyriakides is pushing the plan after lobbying from health ministers following last winter’s shortages. Painkillers for children were among those affected....
...Zipline plans to introduce that service to the UK at a later stage....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Others in the sector were down more than 3 per cent, including Solventum, the healthcare group that was spun out from 3M earlier this week....
...Aardvark plans to use the proceeds from its pre-IPO round to fund a late-stage clinical study into ARD-101’s efficacy on Prader-Willi patients and into patients withdrawing from GLP-1 drugs after weight...
...Almost 36 per cent of shareholders voted against the plans, under which Soriot could earn annual incentive payments based on long-term performance worth up to 850 per cent of his almost £1.5mn base salary...
...“The next few days will be crucial because at the moment there’s no plan,” they said....
...Matthew Taylor, chief executive of the NHS Confederation, which represents health groups across the country, said the £3.4bn additional investment in technology over the next parliament had the potential...
...The shares fell about 8 per cent to €26 on Tuesday, giving the group a market value of €25.6bn....
...In March, officials from 194 countries came together to agree on a global plan to deal with a threat known as “Disease X”....
...A decade later, that difference had reached more than two-thirds, the group said. “Europe is losing R&D....
...Joe Biden, his Democratic successor, reversed the plan....
...Ultimately, the environment remains difficult for individuals or advisers to plan due to a lack of detail about how exactly future reforms would work....
...in the age group....
...Yet Netanyahu has presented no clear plan about who will administer Gaza or maintain civil order. Still, the IDF insists the battle at al-Shifa represents its war plan in action....
...The company plans to “move forward as quickly as possible” with further trials in MASH for the drug....
...It has abandoned plans for two treatments already. It is working on developing a once-a-day version of its own obesity pill danuglipron after dropping plans for a twice-daily pill....
...“It’s an important milestone,” he said, adding that the group could now focus on its 2023-25 growth plan. Jakobs said the company had made changes to avoid further safety issues....
...The industry group is urging the GDC to increase the number of ORE exam places available as well as the frequency of tests....
...Novo Nordisk has struck a €1bn deal for a German biotech developing ribonucleic acid-based therapies to treat heart disease, as the Danish group invests the windfall from its best-selling diabetes and weight...
...Bondholders who bought into a diverse group do not like the prospect of holding debt in a smaller company riddled with problems....
International Edition